Patents by Inventor Birgit Schäfer

Birgit Schäfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYDROPHILIC PHOSPHATE GROUP CONTAINING DEHYDRATED PARTIALLY PURIFIED BONE REPLACEMENT MATERIAL
    Publication number: 20150182556
    Abstract: The invention provides: —A hydrophilic dehydrated partially purified bone replacement material of natural origin, wherein substantially all non-collagenous organic material is removed while inorganic, porous osseous structure and collagenous structure of natural bone are substantially preserved, characterized in that the bone replacement material contains 0.05 to 1.5 w/w % of at least one of a saccharide or a sugar alcohol, and 0.7 to 5.6 w/w % of a phosphate group selected from the group consisting of phosphate HPO42? and H2PO4?, this phosphate group being part of a physiologically acceptable salt and—a process for preparing a hydrophilic dehydrated partially purified bone replacement material.
    Type: Application
    Filed: July 29, 2013
    Publication date: July 2, 2015
    Applicant: GEISTLICH PHARMA AG
    Inventors: Cornel Imhof, Lothar Schlösser, Birgit Schäfer, Michael Bufler
  • RECOMBINANT VIRAL VECTORS AND METHODS FOR INDUCING AN IMMUNE RESPONSE TO YELLOW FEVER VIRUS
    Publication number: 20140255440
    Abstract: The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to yellow fever virus. The invention provides recombinant viral vectors based on the non-replicating modified vaccinia virus Ankara or based on a D4R-defective vaccinia virus. When administered according to methods of the invention, the recombinant viral vectors induce a broad immune response to yellow fever virus and demonstrate an excellent safety profile.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 11, 2014
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Falko-Günter Falkner, Birgit Schäfer, Georg Holzer, P. Noel Barrett, Hartmut Ehrlich
  • Recombinant Viral Vectors and Methods for Inducing an Immune Response to Yellow Fever Virus
    Publication number: 20120328649
    Abstract: The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to yellow fever virus. The invention provides recombinant viral vectors based on the non-replicating modified vaccinia virus Ankara or based on a D4R-defective vaccinia virus. When administered according to methods of the invention, the recombinant viral vectors induce a broad immune response to yellow fever virus and demonstrate an excellent safety profile.
    Type: Application
    Filed: September 22, 2011
    Publication date: December 27, 2012
    Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.
    Inventors: Falko-Günter Falkner, Birgit Schäfer, Georg Holzer, P. Noel Barrett, Hartmut Ehrlich
  • Pharmaceutically Active Antiviral Peptides
    Publication number: 20090215699
    Abstract: The inventive peptides were found to have strong antiviral activity against HIV in general and particularly strong drug-resistant HIV activity without exerting any toxic or antiproliferative effects on cells. Consequently, using of the inventive peptides improves the conventional HIV therapy with its toxic side effects.
    Type: Application
    Filed: January 5, 2006
    Publication date: August 27, 2009
    Applicant: FOUNDATION FOR FATEL RARE DISEASES
    Inventors: Gerald Bacher, Karl Heinrich Wiesmüller, Birgit Schäfer, Joachim Hauber